JMD Association for Molecular Pathology 2008 Annual Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Przybylski, G. K.
Right arrow Articles by Salhany, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Przybylski, G. K.
Right arrow Articles by Salhany, K. E.
JMD 2000, Vol. 2, No. 1
Copyright © 2000 American Society for Investigative Pathology & Association for Molecular Pathology

Hepatosplenic and Subcutaneous Panniculitis-Like {gamma}/{delta} T Cell Lymphomas Are Derived from Different V{delta} Subsets of {gamma}/{delta} T Lymphocytes

Grzegorz K. Przybylski*, Hong Wu{dagger}, William R. Macon{ddagger}, Janet Finan{dagger}, Debra G. B. Leonard{dagger}, Raymond E. Felgar{ddagger}, Joseph A. DiGiuseppe§, Peter C. Nowell{dagger}, Steven H. Swerdlow, Marshall E. Kadin||, Mariusz A. Wasik{dagger} and Kevin E. Salhany{dagger}

From the Institute of Human Genetics, * Poznan, Poland; the University of Pennsylvania, {dagger} Philadelphia, Pennsylvania; Vanderbilt University, {ddagger} Nashville, Tennessee; the Johns Hopkins University, § Baltimore, Maryland; the University of Pittsburgh, Pittsburgh, Pennsylvania; and Harvard University, || Boston, Massachusetts

Gamma/delta T cell lymphomas ({gamma}/{delta} TCL) represent rare, often aggressive types of T cell malignancy that are clinically and pathologically diverse. Most {gamma}/{delta} TCL occur as a hepatosplenic or subcutaneous type. To date, analysis of the T cell receptor {delta} (TCR{delta}) gene repertoire of hepatosplenic {gamma}/{delta} TCL ({gamma}/{delta} HSTCL) and subcutaneous panniculitis-like {gamma}/{delta} TCL ({gamma}/{delta} SPTCL) has been reported only in a limited number of cases. In this study we analyzed 11 {gamma}/{delta} HSTCL and 4 {gamma}/{delta} SPTCL by polymerase chain reaction and immunostaining to determine their usage of the V{delta} subtypes (V{delta}1–6). It is noteworthy that 10 of 11 {gamma}/{delta} HSTCL expressed the V{delta}1 gene. The remaining case also expressed T cell receptor {delta} (TCR{delta}) as determined by flow cytometry and TCR{delta} rearrangement in Southern blot. However, the V{delta} gene expressed by this lymphoma could not be determined, which suggests usage of an as yet unidentified V{delta} gene. In striking contrast to the {gamma}/{delta} HSTCL, all 4 {gamma}/{delta} SPTCL expressed the V{delta}2 gene. Our data demonstrate that {gamma}/{delta} HSTCL are preferentially derived from the V{delta}1 subset of {gamma}/{delta} T lymphocytes, whereas {gamma}/{delta} SPTCL are preferentially derived from the V{delta}2 subset. The pattern of V{delta} gene expression in HSTCL and SPTCL corresponds to the respective, predominant {gamma}/{delta} T cell subsets normally found in the spleen and skin. This finding suggests that {gamma}/{delta} TCL are derived from normal {gamma}/{delta} T lymphocytes which reside in the affected tissues. Furthermore, the selective, lymphoma type-specific V{delta} gene segment usage may provide a molecular tool to distinguish better among various types of {gamma}/{delta} TCL lymphoma particularly in the clinically advanced, widely disseminated cases.




This article has been cited by other articles:


Home page
BloodHome page
M. A. Rizvi, A. M. Evens, M. S. Tallman, B. P. Nelson, and S. T. Rosen
T-cell non-Hodgkin lymphoma
Blood, February 15, 2006; 107(4): 1255 - 1264.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Belhadj, F. Reyes, J.-P. Farcet, H. Tilly, C. Bastard, R. Angonin, E. Deconinck, F. Charlotte, V. Leblond, E. Labouyrie, et al.
Hepatosplenic {gamma}{delta} T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients
Blood, December 15, 2003; 102(13): 4261 - 4269.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. R. Toro, D. J. Liewehr, N. Pabby, L. Sorbara, M. Raffeld, S. M. Steinberg, and E. S. Jaffe
Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma
Blood, May 1, 2003; 101(9): 3407 - 3412.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
I. K. Aronson and V. C. Fiedler
Of Mice and Men: The Road to Understanding the Complex Nature of Adipose Tissue and Lipoatrophy
Arch Dermatol, January 1, 2003; 139(1): 81 - 83.
[Full Text] [PDF]


Home page
Arch DermatolHome page
M. E. Kadin
Cutaneous {gamma}{delta} T-Cell Lymphomas--How and Why Should They Be Recognized?
Arch Dermatol, August 1, 2000; 136(8): 1052 - 1054.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology and the Association for Molecular Pathology.